paeonol has been researched along with trinitrobenzenesulfonic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, T; Goto, H; Hasegawa, M; Ishiguro, K; Kadomatsu, K; Maeda, O; Niwa, Y; Ohmiya, N; Xavier, R | 1 |
| Pu, YQ; Wang, B; Xu, BL; Zhang, T; Zong, SY | 1 |
2 other study(ies) available for paeonol and trinitrobenzenesulfonic acid
| Article | Year |
|---|---|
Paeonol attenuates TNBS-induced colitis by inhibiting NF-kappaB and STAT1 transactivation.
Topics: Acetophenones; Animals; Anti-Inflammatory Agents; Colitis; Colon; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Enzymologic; Humans; Interferon-gamma; Jurkat Cells; Mice; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide Synthase Type II; Promoter Regions, Genetic; RNA, Messenger; STAT1 Transcription Factor; Transcriptional Activation; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2006 |
Study on the physicochemical properties and anti-inflammatory effects of paeonol in rats with TNBS-induced ulcerative colitis.
Topics: Acetophenones; Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Colon; Disease Models, Animal; Humans; Interleukin-17; Interleukin-6; Male; Paeonia; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Trinitrobenzenesulfonic Acid | 2017 |